JAMES B BREITMEYER
CIK 1244823 · Chief Executive Officer · last filed 2026-05-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
65
Lifetime Open-Market Net
-$1.45M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Oncternal Therapeutics, Inc. (ONCT) Delisted | Chief Executive Officer | 443,767 | $0.53 | $233.7K | $86.0K | 22 | 2024-02-15 |
| OTONOMY, INC. (OTIC) Delisted | Director | — | $0.08 | — | $0 | 5 | 2022-06-23 |
| ZOGENIX, INC. (ZGNX) Delisted | Director | 6,250 | $26.68 | $166.8K | -$500.0K | 10 | 2021-05-28 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | EVP, CMO | 10,000 | — | — | -$1.04M | 26 | 2012-03-16 |
Recent Filings · Page 3 of 7
65 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-07-31 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-31 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-29 | ZOGENIX, INC. (ZGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-25 | OTONOMY, INC. (OTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-18 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-09 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-18 | ZOGENIX, INC. (ZGNX) Delisted | Mixed | — | -$205.1K | EDGAR |
| 2019-11-27 | ZOGENIX, INC. (ZGNX) Delisted | Mixed | — | -$205.1K | EDGAR |
| 2019-09-16 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-20 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.